GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (TSE:4523) » Definitions » Cyclically Adjusted Price-to-FCF

Eisai Co (TSE:4523) Cyclically Adjusted Price-to-FCF : 7.51 (As of Apr. 27, 2024)


View and export this data going back to 1961. Start your Free Trial

What is Eisai Co Cyclically Adjusted Price-to-FCF?

As of today (2024-04-27), Eisai Co's current share price is 円6240.00. Eisai Co's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was 円831.11. Eisai Co's Cyclically Adjusted Price-to-FCF for today is 7.51.

The historical rank and industry rank for Eisai Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

TSE:4523' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 5.64   Med: 8.46   Max: 14.6
Current: 7.51

During the past years, Eisai Co's highest Cyclically Adjusted Price-to-FCF was 14.60. The lowest was 5.64. And the median was 8.46.

TSE:4523's Cyclically Adjusted Price-to-FCF is ranked better than
92.62% of 325 companies
in the Drug Manufacturers industry
Industry Median: 32.81 vs TSE:4523: 7.51

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Eisai Co's adjusted free cash flow per share data for the three months ended in Dec. 2023 was 円3.741. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is 円831.11 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Eisai Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Eisai Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eisai Co Cyclically Adjusted Price-to-FCF Chart

Eisai Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.45 8.54 8.97 6.52 8.95

Eisai Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.41 8.95 11.54 9.83 8.49

Competitive Comparison of Eisai Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Eisai Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eisai Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eisai Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Eisai Co's Cyclically Adjusted Price-to-FCF falls into.



Eisai Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Eisai Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=6240.00/831.11
=7.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eisai Co's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Eisai Co's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=3.741/106.8000*106.8000
=3.741

Current CPI (Dec. 2023) = 106.8000.

Eisai Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 319.143 95.700 356.160
201406 65.982 98.000 71.907
201409 310.095 98.500 336.225
201412 -8.085 97.900 -8.820
201503 436.425 97.900 476.100
201506 -146.263 98.400 -158.749
201509 287.678 98.500 311.919
201512 225.549 98.100 245.552
201603 408.474 97.900 445.608
201606 -103.142 98.100 -112.289
201609 398.908 98.000 434.728
201612 168.938 98.400 183.360
201703 315.059 98.100 343.000
201706 -185.675 98.500 -201.321
201709 169.983 98.800 183.747
201712 290.127 99.400 311.726
201803 1,472.246 99.200 1,585.039
201806 94.825 99.200 102.090
201809 480.978 99.900 514.199
201812 64.181 99.700 68.752
201903 421.401 99.700 451.410
201906 -426.548 99.800 -456.466
201909 111.815 100.100 119.299
201912 195.242 100.500 207.481
202003 851.926 100.300 907.136
202006 -28.277 99.900 -30.230
202009 55.679 99.900 59.525
202012 -149.777 99.300 -161.089
202103 620.541 99.900 663.401
202106 -101.676 99.500 -109.136
202109 1,054.881 100.100 1,125.487
202112 -20.316 100.100 -21.676
202203 127.229 101.100 134.402
202206 -41.646 101.800 -43.691
202209 -96.305 103.100 -99.761
202212 -49.021 104.100 -50.292
202303 60.299 104.400 61.685
202306 14.209 105.200 14.425
202309 46.235 106.200 46.496
202312 3.741 106.800 3.741

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Eisai Co  (TSE:4523) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Eisai Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Eisai Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Eisai Co (TSE:4523) Business Description

Industry
Traded in Other Exchanges
Address
4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.

Eisai Co (TSE:4523) Headlines

No Headlines